References
- Amankwah EK, Sellers TA, Park JY, (2012). Gene variants in the angiogenesis pathway and prostate cancer. Carcinogenesis, 33, 1259-69. https://doi.org/10.1093/carcin/bgs150
- Askari F, Parizi MK, Jessri M, Rashidkhani B (2014). Dietary patterns in relation to prostate cancer in Iranian Men: A Case-Control Study. Asian Pac J Cancer Prev, 15, 2159-63. https://doi.org/10.7314/APJCP.2014.15.5.2159
- Daugherty SE, Shugart YY, Platz EA, et al (2007). Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate, 67, 1487-97. https://doi.org/10.1002/pros.20635
- Doolan G, Benke G, Giles G (2014). An update on occupation and prostate cancer. Asian Pac J Cancer Prev, 15, 501-16. https://doi.org/10.7314/APJCP.2014.15.2.501
- Ferdinandusse S, Denis S, L IJ, et al (2000). Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res, 41, 1890-96.
- FitzGerald LM, Thomson R, Polanowski A, et al (2008). Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population. Prostate, 68, 1373-79. https://doi.org/10.1002/pros.20798
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jiang N, Zhu S, Chen J, Niu Y, Zhou L (2013). A-methylacyl- CoA racemase (AMACR) and prostate-cancer risk: a metaanalysis of 4,385 participants. PLoS One, 8, 74386. https://doi.org/10.1371/journal.pone.0074386
- Lee SJ, Joung JY, Yoon H, et al (2013). Genetic variations of alpha -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans. Biomed Res Int, 2013, 394285.
- Lloyd MD, Yevglevskis M, Lee GL, et al (2013). alpha- Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S. Prog Lipid Res, 52, 220-30. https://doi.org/10.1016/j.plipres.2013.01.001
- Mahmoud AM, Yang W, Bosland MC (2014). Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol, 140, 116-32. https://doi.org/10.1016/j.jsbmb.2013.12.010
- Mazzola CR, Ghoneim T, Shariat SF, (2011). Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer. Prog Urol, 21, 1-10. https://doi.org/10.1016/j.purol.2010.07.004
- Ouyang B, Leung YK, Wang V, et al (2011). Alpha-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. Urology, 77, 249.e1-249.e7.
- Wang YC, Xia SJ (2009). An update of biomarkers in prostate cancer tissue. Zhonghua Nan Ke Xue, 15, 1039-43.
- Wright JL, Neuhouser ML, Lin DW, et al (2011). AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. Prostate, 71, 498-506. https://doi.org/10.1002/pros.21267
- Yang B, Chen WH, Wen XF, Liu H, Liu F (2013). Role of DNA repair-related gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42. https://doi.org/10.7314/APJCP.2013.14.10.5839
- Zhang LL, Sun L, Zhu XQ, et al (2014). rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in Northern Han Chinese. Asian Pac J Cancer Prev, 15, 3129-32. https://doi.org/10.7314/APJCP.2014.15.7.3129
- Zha S, Ferdinandusse S, Denis S, et al (2003). Alpha-methylacyl- CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res, 63, 7365-76.
- Zheng SL, Chang BL, Faith DA, et al (2002). Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res, 62, 6485-8.